Your browser doesn't support javascript.
loading
Buyang Huanwu decoction ameliorates bleomycin-induced pulmonary fibrosis in rats by attenuating the apoptosis of alveolar type II epithelial cells mediated by endoplasmic reticulum stress.
Zhou, Piao; Wu, Xinhui; Chen, Keling; Du, Jing; Wang, Fei.
Afiliação
  • Zhou P; Department of Integrated Traditional and Western Medicine, West China Hospital of Sichuan University, China; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Wu X; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Chen K; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Du J; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Wang F; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China. Electronic address: wangfei896@163.com.
J Ethnopharmacol ; 319(Pt 3): 117300, 2024 Jan 30.
Article em En | MEDLINE | ID: mdl-37813290
ABSTRACT
ETHNOPHARMACOLOGICAL RELEVANCE According to the theory of traditional Chinese medicine, the pathogenesis of idiopathic pulmonary fibrosis (IPF) can be attributed to qi deficiency and blood stasis. Buyang Huanwu decoction (BHD), a representative Chinese herbal prescription for qi deficiency and blood stasis syndrome, is widely used to treat IPF in clinical practice. However, its potential mechanisms against IPF remain unclear. AIMS OF THE STUDY This study was carried out to explore the therapeutic effects and underlying mechanisms of BHD on bleomycin (BLM)-induced pulmonary fibrosis in rats. MATERIALS AND

METHODS:

UPLC-MS/MS method was performed to identify the quality of BHD used in this study. Concurrently, a IPF rat model was established by single intratracheal injection of BLM. Pulmonary function test, H&E staining, Masson staining, hydroxyproline assay were conducted to evaluate the therapeutic effects of BHD on BLM-induced pulmonary fibrosis in rats, and the regulatory effect of BHD on endoplasmic reticulum stress (ERS)-mediated alveolar type II epithelial cells (AEC2s) apoptosis in rats was further investigated by TUNEL staining, Western blot, real-time fluorescence quantitative PCR and immunofluorescence co-staining to reveal the potential mechanisms of BHD against IPF.

RESULTS:

The UPLC-MS/MS analysis showed that the BHD we used complied with the relevant quality control standards. The data from animal experiments confirmed that BHD administration ameliorated BLM-induced pulmonary function decline, lung fibrotic pathological changes and collagen deposition in rats. Further mechanism study revealed that BHD increased the Bcl-2 protein expression, decreased the Bax protein expression and inhibited the cleavage of CASP3 via suppressing the activation of PERK-ATF4-CHOP pathway under continuous ERS, thereby alleviating BLM-induced AEC2s apoptosis of rats.

CONCLUSION:

This study demonstrated that BHD ameliorated BLM-induced pulmonary fibrosis in rats by suppressing ERS-mediated AEC2s apoptosis. Our findings can provide some fundamental research basis for the clinical application of BHD in the treatment of IPF.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bleomicina / Fibrose Pulmonar Idiopática Tipo de estudo: Guideline / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bleomicina / Fibrose Pulmonar Idiopática Tipo de estudo: Guideline / Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article